BioSpace News Archive

GBS Inc., a life sciences company that develops non-invasive, real-time point of care diagnostic tests for patients and their primary health practitioners, announced the execution of a sponsored research agreement with Johns Hopkins Bloomberg School of Public Health to accelerate development of next-generation saliva-based diagnostic tests.

further advancing the science of urology, improving health care quality and ultimately improving the lives of the millions of people affected by prostate cancer, bladder cancer and other urologic disease.

Central Logic, the leading healthcare access and orchestration company, announced today that NEJM Catalyst, a renowned healthcare journal, has published a case study on the origin and successful outcomes of the Arizona Surge Line.

Blackfynn, a company using a systematic approach that combines data, technology and disease-specific clinical expertise to develop a growing pipeline of targeted, clinical-stage therapeutics for Parkinson’s and neurodegeneration, today announced that it has entered into an agreement with an undisclosed partner to acquire rights to a Phase 3-ready drug to treat Parkinson’s.

Metabolon, Inc. has entered into to a multi-year collaborative agreement with Cleveland Clinic to provide Metabolon’s Precision Metabolomics™ services in support of drug development and related research efforts.

Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, announced the publication of new clinical data in the International Journal of Cardiology.

Acadia Pharmaceuticals Inc. announced that it will participate at the following investor conferences

Thykamine™ monotherapy achieved positive results by reaching the study’s primary endpoint with statistical significance, delivering significant improvement in skin clearance as determined by the Investigator Global Assessment (IGA)

KEY CAPITAL CORPORATION advises that it continues to work with Immunitor, its partner and Licensor, to progress further research and development of its breakthrough therapeutic vaccines, and for several unique supplements.

Rx Redefined - a health tech company transforming the way physicians prescribe and patients obtain essential medical supplies - announced the successful completion of its $2M seed funding round, led by Silverton Partners with participation from Saturn Five.